Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide Obtained from Hen Ovotransferrin

2006 ◽  
Vol 53 (2) ◽  
pp. 495-501 ◽  
Author(s):  
Nai-Yuan Lee ◽  
Juei-Tang Cheng ◽  
Toshiki Enomoto ◽  
Ichiro Nakamura
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Antihypertensive Effect ◽  
Converting Enzyme ◽  
Inhibitory Peptide

scholarly journals Long-Term Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide LAP

2011 ◽  
Vol 34 (5) ◽  
pp. 358-364 ◽  
Author(s):  
Luo Ming ◽  
Shen Yi ◽  
Liu Chi ◽  
Huan Zheng ◽  
Zhanxia Li ◽  
...  
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Antihypertensive Effect ◽  
Converting Enzyme ◽  
Inhibitory Peptide

A novel angiotensin-converting enzyme inhibitory peptide from rabbit meat protein hydrolysate: Identification, molecular mechanism, and antihypertensive effect in vivo

2021 ◽  
Author(s):  
Junbo Chen ◽  
Xiaodong Yu ◽  
Wangxiang Huang ◽  
Chen Wang ◽  
Qiyi He
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Antihypertensive Effect ◽  
Protein Hydrolysate ◽  
Converting Enzyme ◽  
Inhibitory Effects ◽  
Inhibitory Peptide ◽  
Rabbit Meat ◽  
Natural Foods ◽  
Ace Inhibitory

Bioactive peptides exhibiting angiotensin-converting enzyme (ACE) inhibitory effects and extracted from natural foods have potential as healthy and safe therapeutics for high blood pressure. A novel ACE inhibitory tetrapeptide Trp-Gly-Ala-Pro...

scholarly journals Comparative efficacy Noliprel forte and Ko-renitec at high risk arterial hypertension patients

2006 ◽  
Vol 12 (1) ◽  
pp. 56-58
Author(s):  
S. Nedogoda ◽  
T. Chalyabi ◽  
V. Tioina ◽  
Y. Brel ◽  
E. Prokhorova
Keyword(s):  
High Risk ◽  
Angiotensin Converting Enzyme ◽  
Arterial Hypertension ◽  
Cardiovascular Events ◽  
Antihypertensive Effect ◽  
Fixed Combination ◽  
Clinical Effects ◽  
Arterial Elasticity ◽  
Converting Enzyme ◽  
Comparative Efficacy

The aim of the study was to compare i he clinical efficacy and tolerance of fixed combinations of angiotensin-converting enzyme (ACE) and diuretic noliprel and co-renitec in patients with mild and moderate arterial hypertension with high risk of cardiovascular events. All investigated patients didn't achieved normal AP level with monotherapy. The study was blinded, randomised and performed in parallel groups (20 subjects in each group). The clinical effects were evaluated after 6 months of therapy by 1 tablet of noliprel-forte (4 mg / 12.5 mg) or co-renitec (20 mg / 12.5 mg). The antihypertensive effect was comparable for both dings, but fixed combination of noliprel-forte show advantage in reducing of LV hypertrophy and improvement of arterial elasticity.

Evaluation of the osteoprotective potential of whey derived-antioxidative (YVEEL) and angiotensin-converting enzyme inhibitory (YLLF) bioactive peptides in ovariectomised rats

2018 ◽  
Vol 9 (9) ◽  
pp. 4791-4801 ◽  
Author(s):  
Masum Pandey ◽  
Suman Kapila ◽  
Rajeev Kapila ◽  
Ritu Trivedi ◽  
Anirudh Karvande
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Bioactive Peptides ◽  
Converting Enzyme ◽  
Inhibitory Peptide ◽  
Ace Inhibitory Peptide ◽  
Antioxidative Peptide ◽  
Ace Inhibitory ◽  
Ovariectomised Rats

Whey-derived antioxidative peptide showed an enhanced osteoprotective effect as compared to ACE inhibitory peptide.

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

1978 ◽  
Vol 298 (18) ◽  
pp. 991-995 ◽  
Author(s):  
Haralambos Gavras ◽  
Hans R. Brunner ◽  
Gustave A. Turini ◽  
Glenn R. Kershaw ◽  
Charles P. Tifft ◽  
...  
Keyword(s):  
Angiotensin Converting Enzyme ◽  
Angiotensin Converting Enzyme Inhibitor ◽  
Antihypertensive Effect ◽  
Enzyme Inhibitor ◽  
Converting Enzyme ◽  
Converting Enzyme Inhibitor
Sign in / Sign up

Export Citation Format

Share Document